Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Timing and uptake of germline testing in patients with somatic BRCA1/2 pathogenic or likely pathogenic variants in solid tumors: A real-world study from community oncology practices. Identifying ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Four brothers who were all diagnosed with prostate cancer within six months of each other said going through treatment ...

The UCLA trial is currently enrolling patients.